Transplantation versus resection for patients with combined hepatocellular carcinoma-cholangiocarcinoma

Journal of Surgical Oncology

Volumn 107, Issue 6, 2013, Pages 608-612

  Groeschl, Ryan T ^a   Turaga, Kiran K ^a   Gamblin, T Clark ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

cholangiocarcinoma; hepatectomy; hepatocellular carcinoma; liver; surgery; transplantation

Indexed keywords

ADULT; AGED; BILE DUCT CARCINOMA; CANCER REGISTRY; CANCER SURVIVAL; COHORT ANALYSIS; COMPARATIVE STUDY; CONFERENCE PAPER; DEATH; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER RESECTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TUMOR VOLUME;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CHOLANGIOCARCINOMA; FEMALE; HEPATECTOMY; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; NEOPLASMS, COMPLEX AND MIXED; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SEER PROGRAM; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84876411315     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.23289     Document Type: Conference Paper

References (36)

1. Allen RA, Lisa JR:, Combined liver cell and bile duct carcinoma. Am J Pathol 1949; 25: 647-655.
2. Goodman ZD, Ishak KG, Langloss JM, et al.: Combined hepatocellular- cholangiocarcinoma. A histologic and immunohistochemical study. Cancer 1985; 55: 124-135.
3. Yeh MM:, Pathology of combined hepatocellular-cholangiocarcinoma. J Gastroenterol Hepatol 2010; 25: 1485-1492.
4. Taguchi J, Nakashima O, Tanaka M, et al.: A clinicopathological study on combined hepatocellular and cholangiocarcinoma. J Gastroenterol Hepatol 1996; 11: 758-764.
5. Theise ND, Yao JL, Harada K, et al.: Hepatic "stem cell" malignancies in adults: Four cases. Histopathology 2003; 43: 263-271.
6. Fujii H, Zhu XG, Matsumoto T, et al.: Genetic classification of combined hepatocellular-cholangiocarcinoma. Hum Pathol 2000; 31: 1011-1017.
7. Cazals-Hatem D, Rebouissou S, Bioulac-Sage P, et al.: Clinical and molecular analysis of combined hepatocellular-cholangiocarcinomas. J Hepatol 2004; 41: 292-298.
8. Wachtel MS, Zhang Y, Xu T, et al.: Combined hepatocellular cholangiocarcinomas; analysis of a large database. Clin Med Pathol 2008; 1: 43-47.
9. Wang J, Wang F, Kessinger A:, Outcome of combined hepatocellular and cholangiocarcinoma of the liver. J Oncol 2010; 2010: 917356.
10. Nathan H, Pawlik TM:, Limitations of claims and registry data in surgical oncology research. Ann Surg Oncol 2008; 15: 415-4123.
11. Fritz AG:, International classification of diseases for oncology: ICD-O, 3rd edition. Geneva: World Health Organization; 2000.
12. Bruix J, Sherman M, Llovet JM, et al.: Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 2001; 35: 421-430.
13. Torzilli G, Minagawa M, Takayama T, et al.: Accurate preoperative evaluation of liver mass lesions without fine-needle biopsy. Hepatology 1999; 30: 889-893.
14. Blechacz B, Komuta M, Roskams T, et al.: Clinical diagnosis and staging of cholangiocarcinoma. Nat Rev Gastroenterol Hepatol 2011; 8: 512-522.
15. Rimola J, Forner A, Reig M, et al.: Cholangiocarcinoma in cirrhosis: Absence of contrast washout in delayed phases by magnetic resonance imaging avoids misdiagnosis of hepatocellular carcinoma. Hepatology 2009; 50: 791-798.
16. Kassahun WT, Hauss J:, Management of combined hepatocellular and cholangiocarcinoma. Int J Clin Pract 2008; 62: 1271-1278.
17. Panjala C, Senecal DL, Bridges MD, et al.: The diagnostic conundrum and liver transplantation outcome for combined hepatocellular-cholangiocarcinoma. Am J Transplant 2010; 10: 1263-1267.
18. Sapisochin G, Fidelman N, Roberts JP, et al.: Mixed hepatocellular cholangiocarcinoma and intrahepatic cholangiocarcinoma in patients undergoing transplantation for hepatocellular carcinoma. Liver Transpl 2011; 17: 934-942.
19. Chantajitr S, Wilasrusmee C, Lertsitichai P, et al.: Combined hepatocellular and cholangiocarcinoma: Clinical features and prognostic study in a Thai population. J Hepatobiliary Pancreat Surg 2006; 13: 537-542.
20. Kim KH, Lee SG, Park EH, et al.: Surgical treatments and prognoses of patients with combined hepatocellular carcinoma and cholangiocarcinoma. Ann Surg Oncol 2009; 16: 623-629.
21. Tickoo SK, Zee SY, Obiekwe S, et al.: Combined hepatocellular- cholangiocarcinoma: a histopathologic, immunohistochemical, and in situ hybridization study. Am J Surg Pathol 2002; 26: 989-997.
22. Hanish SI, Knechtle SJ:, Liver transplantation for the treatment of hepatocellular carcinoma. Oncology (Williston Park) 2011; 25: 752-757.
23. Heimbach JK, Gores GJ, Haddock MG, et al.: Liver transplantation for unresectable perihilar cholangiocarcinoma. Semin Liver Dis 2004; 24: 201-207.
24. Meyer CG, Penn I, James L:, Liver transplantation for cholangiocarcinoma: Results in 207 patients. Transplantation 2000; 69: 1633-1637.
25. Shimoda M, Farmer DG, Colquhoun SD, et al.: Liver transplantation for cholangiocellular carcinoma: Analysis of a single-center experience and review of the literature. Liver Transpl 2001; 7: 1023-1033.
26. de Jong MC, Nathan H, Sotiropoulos GC, et al.: Intrahepatic cholangiocarcinoma: An international multi-institutional analysis of prognostic factors and lymph node assessment. J Clin Oncol 2011; 29: 3140-3145.
27. Nguyen KT, Steel J, Vanounou T, et al.: Initial presentation and management of hilar and peripheral cholangiocarcinoma: Is a node-positive status or potential margin-positive result a contraindication to resection ? Ann Surg Oncol 2009; 16: 3308-3315.
28. Chan AC, Lo CM, Ng IO, et al.: Liver transplantation for combined hepatocellular cholangiocarcinoma. Asian J Surg 2007; 30: 143-146.
29. Jarnagin WR, Weber S, Tickoo SK, et al.: Combined hepatocellular and cholangiocarcinoma: Demographic, clinical, and prognostic factors. Cancer 2002; 94: 2040-2046.
30. Koh KC, Lee H, Choi MS, et al.: Clinicopathologic features and prognosis of combined hepatocellular cholangiocarcinoma. Am J Surg 2005; 189: 120-125.
31. Liu CL, Fan ST, Lo CM, et al.: Hepatic resection for combined hepatocellular and cholangiocarcinoma. Arch Surg 2003; 138: 86-90.
32. Yano Y, Yamamoto J, Kosuge T, et al.: Combined hepatocellular and cholangiocarcinoma: A clinicopathologic study of 26 resected cases. Jpn J Clin Oncol 2003; 33: 283-287.
33. Zhan Q, Shen BY, Deng XX, et al.: Clinical and pathological analysis of 27 patients with combined hepatocellular-cholangiocarcinoma in an Asian center. J Hepatobiliary Pancreat Sci 2012; 19: 361-369.
34. Koniaris LG, Levi DM, Pedroso FE, et al.: Is surgical resection superior to transplantation in the treatment of hepatocellular carcinoma ? Ann Surg 2011; 254: 527-537; discussion 37-38.
35. Kim GM, Jeung HC, Kim D, et al.: A case of combined hepatocellular- cholangiocarcinoma with favorable response to systemic chemotherapy. Cancer Res Treat 2010; 42: 235-238.
36. Maganty K, Levi D, Moon J, et al.: Combined hepatocellular carcinoma and intrahepatic cholangiocarcinoma: Outcome after liver transplantation. Dig Dis Sci 2010; 55: 3597-3601.